Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06446869

Menopausal Symptoms Probiotic Study

Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the Combination of Levilactobacillus Brevis KABP-052, Lactiplantibacillus Plantarum KABP-051 and Pediococcus Acidilactici KABP-021 on Menopausal Symptoms and Quality of Life in Peri- and Post-menopausal Women

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Community Pharmacology Services Ltd · Academic / Other
Sex
Female
Age
42 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In this study, we want to investigate if the active product consisting of a probiotic blend can potentiate the recirculation of active oestrogens into the bloodstream and help to mitigate menopause symptoms, which are closely related to oestrogens levels

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGyntima MenopauseCombination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021
OTHERPlaceboPlacebo comparator

Timeline

Start date
2024-09-10
Primary completion
2026-07-25
Completion
2026-10-25
First posted
2024-06-06
Last updated
2026-01-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06446869. Inclusion in this directory is not an endorsement.